R. Xu

Application of pharmacodynamic assays in a phase Ia trial of Apo2L/TRAIL in patients with advanced tumors

R. Herbst, D. Branstetter, G. Eckhardt, 2007 .

Diagnostic application of next-generation sequencing in ZMYM2-FGFR1 8p11 myeloproliferative syndrome: A case report

Shichun Tu, Yadan Wang, Xiaofei Wu, 2016, Cancer biology & therapy.

Evaluation of pharmacodynamic biomarkers in a Phase 1a trial of dulanermin (rhApo2L/TRAIL) in patients with advanced tumours

R. Herbst, D. Branstetter, S. Eckhardt, 2011, British Journal of Cancer.

Serum microRNA-302b: the novel biomarker for diagnosis of acute myocardial infarction

R. Xu, X. Zhao, S. Yang, 2017, British journal of biomedical science.

Homogeneous BTK Occupancy Assay for Pharmacodynamic Assessment of Tirabrutinib (GS-4059/ONO-4059) Target Engagement

Helen Yu, N. Pagratis, A. Billin, 2018, SLAS discovery : advancing life sciences R & D.

Cytokeratin-18 Is a Useful Serum Biomarker for Early Determination of Response of Breast Carcinomas to Chemotherapy

S. Linder, M. Toi, W. Aulitzky, 2007, Clinical Cancer Research.

Conatumumab, a fully human agonist antibody to death receptor 5, induces apoptosis via caspase activation in multiple tumor types

A. Coxon, D. Branstetter, I. Foltz, 2010, Cancer biology & therapy.